Weichun Xu

3.5k citations

33 papers · 2.7k indexed · h-index 22

Rheumatology top 0.5%
Immunology top 5%
Hematology top 2%
Psychiatry and Mental health top 2%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Mahboob U. Rahman Désirée van der Heijde Joyce A. Cramer Dennis S. Charney Robert A. Rosenheck Sudha Visvanathan Jonathan Thomas Paul Williamson
Topics: Rheumatoid Arthritis Research and Therapies (12 papers)Autoimmune and Inflammatory Disorders Research (9 papers)Spondyloarthritis Studies and Treatments (6 papers)
Cited by: Rheumatology Hematology Psychiatry and Mental health
Journals: New England Journal of Medicine Journal of Clinical Oncology American Journal of Psychiatry
Partner nations: United States United Kingdom Canada

In The Last Decade

Weichun Xu

33 papers receiving 2.6k citations

Peers

Countries citing papers authored by Weichun Xu

Since Specialization

Citations

This map shows the geographic impact of Weichun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weichun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weichun Xu more than expected).

Fields of papers citing papers by Weichun Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weichun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weichun Xu. The network helps show where Weichun Xu may publish in the future.

Co-authorship network of co-authors of Weichun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weichun Xu. A scholar is included among the top collaborators of Weichun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weichun Xu. Weichun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer 2025 ·The Oncologist ·Emiliano Calvo,Bernard Doger,Joan Carles,Avivit Peer,David Sarid,Bernhard J. Eigl,Anjali Narayan Avadhani,(unknown),Vincent Lin,Shujian Wu,(unknown),John T. Loffredo,(unknown),Weichun Xu,Hong Xie,Aaron R. Hansen	2
2	A global interactive attention-based lightweight denoising network for locating internal defects of CFRP laminates 2022 ·Engineering Applications of Artificial Intelligence ·Bo Yang,Yang Zhang,Shilong Wang,Weichun Xu,Meng Xiao,Yan He,Fan Mo	16
3	Removal of chlorine, microparticles and water from high-viscosity liquids by a sand filter coupling hydrocyclone 2022 ·Process Safety and Environmental Protection ·(unknown),Jianping Li,(unknown),Wenjie Lv,Jianqi Chen,Pengbo Fu,Yan Liu,Weichun Xu,Li Dai,Hualin Wang	7
4	Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study 2017 ·Annals of the Rheumatic Diseases ·Tsutomu Takeuchi,Carter Thorne,George Karpouzas,Shihong Sheng,Weichun Xu,Ravi Rao,Kaiyin Fei,Benjamin Hsu,Paul P. Tak	55
5	Effect of Golimumab on Carotid Atherosclerotic Disease Measures and Cardiovascular Events in Inflammatory Arthritides 2013 ·JCR Journal of Clinical Rheumatology ·Mary Chester Wasko,Elizabeth C. Hsia,Bruce Kirkham,Pierre‐Jean Touboul,Roy Fleischmann,Mark C. Genovese,Eric L. Matteson,Jiandong Lu,Weichun Xu,Mahboob U. Rahman	12
6	Golimumab in psoriatic arthritis: One‐year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo‐controlled trial 2012 ·Arthritis & Rheumatism ·Arthur Kavanaugh,Désirée van der Heijde,Iain B. McInnes,Philip J. Mease,Gerald G. Krueger,Dafna D. Gladman,Juan J. Gómez‐Reino,Kim Papp,Anna Baratelle,Weichun Xu,S. Mudivarthy,M. Mack,Mahboob U. Rahman,Zhenhua Xu,Julie Zrubek,Anna Beutler	169
7	Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study 2012 ·Annals of the Rheumatic Diseases ·Arthur Kavanaugh,Iain B. McInnes,Philip J. Mease,Gerald G. Krueger,Dafna D. Gladman,Désirée van der Heijde,S. Mudivarthy,Weichun Xu,M. Mack,Zhenhua Xu,Anna Beutler	73
8	Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study 2011 ·Annals of the Rheumatic Diseases ·Jürgen Braun,Xenofon Baraliakos,Kay‐Geert Hermann,Désirée van der Heijde,Robert D. Inman,Atul Deodhar,Anna Baratelle,Stephen Xu,Weichun Xu,Benjamin Hsu	72
9	Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients 2011 ·Arthritis & Rheumatism ·Mikkel Østergaard,Paul Emery,Philip G. Conaghan,Roy Fleischmann,Elizabeth C. Hsia,Weichun Xu,Mahboob U. Rahman	74
10	Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis 2011 ·Annals of the Rheumatic Diseases ·Paul Emery,Désirée van der Heijde,Mikkel Østergaard,Philip G. Conaghan,Mark C. Genovese,Edward Keystone,R. Fleischmann,Elizabeth C. Hsia,Weichun Xu,(unknown),Mahboob U. Rahman	36
11	Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twenty‐four–week results of a phase III, multicenter, randomized, double‐blind, placebo‐controlled study of golimumab before methotrexate as first‐line therapy for early‐onset rheumatoid arthritis 2009 ·Arthritis & Rheumatism ·Paul Emery,Roy Fleischmann,Larry W. Moreland,Elizabeth C. Hsia,Ingrid Strusberg,Patrick Durez,Peter Nash,Eric Amante,Melvin Churchill,Won Park,Bernardo A. Pons‐Estel,Mittie K. Doyle,Sudha Visvanathan,Weichun Xu,Mahboob U. Rahman	335
12	Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis 2008 ·Arthritis & Rheumatism ·Désirée van der Heijde,Robert Landewé,Xenofon Baraliakos,Harry Houben,Astrid van Tubergen,Paul Williamson,Weichun Xu,Daniel Baker,Neil Goldstein,Jürgen Braun	380
13	Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two‐year period 2008 ·Arthritis Care & Research ·Jürgen Braun,Atul Deodhar,Ben A. C. Dijkmans,Piet Geusens,Joachim Sieper,Paul Williamson,Weichun Xu,Sudha Visvanathan,Daniel Baker,Neil Goldstein,Désirée van der Heijde	87
14	Clinical and Psychopharmacologic Factors Influencing Family Burden in Refractory Schizophrenia 2000 ·The Journal of Clinical Psychiatry ·Robert A. Rosenheck,Joyce A. Cramer,(unknown),Deborah Perlick,Weichun Xu,(unknown),William Henderson,Dennis S. Charney	27
15	Medication Continuation and Compliance 2000 ·The Journal of Clinical Psychiatry ·Robert A. Rosenheck,Sidney S. Chang,Yeon Hyeon Choe,Joyce A. Cramer,Weichun Xu,Jonathan Thomas,William G. Henderson,Dennis S. Charney	59
16	Antidepressant pharmacotherapy helps some cigarette smokers more than others. 1999 ·Journal of Consulting and Clinical Psychology ·Brian Hitsman,Regina Pingitore,Bonnie Spring,Atul R. Mahableshwarkar,(unknown),(unknown),Jean L. Kristeller,Weichun Xu	87
17	Impact of Clozapine on Negative Symptoms and on the Deficit Syndrome in Refractory Schizophrenia 1999 ·American Journal of Psychiatry ·Robert Rosenheck,Lawrence A. Dunn,Michael Alfred Peszke,Joyce A. Cramer,Weichun Xu,Jonathan Thomas,Dennis S. Charney	61
18	Predictors of differential response to clozapine and haloperidol 1998 ·Biological Psychiatry ·Robert A. Rosenheck,William Lawson,John W. Crayton,Joyce A. Cramer,Weichun Xu,Jonathan Thomas,Marilyn Stolar,Dennis S. Charney	22
19	A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory Schizophrenia 1997 ·New England Journal of Medicine ·Robert A. Rosenheck,Joyce A. Cramer,Weichun Xu,Jonathan Thomas,William Henderson,Linda K. Frisman,Carol L. Fye,Dennis S. Charney	394
20	The P1 Component of the Middle Latency Auditory Potential May Differentiate a Brainstem Subgroup of Alzheimer Disease 1997 ·Alzheimer Disease & Associated Disorders ·Joseph B. Green,(unknown),David Freed,(unknown),Weichun Xu	24

About Weichun Xu

Weichun Xu is a scholar working on Rheumatology, Hematology and Psychiatry and Mental health, having authored 33 papers that have together received 2.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (12 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Spondyloarthritis Studies and Treatments (6 papers). The work is most often cited by research in Rheumatology (1.6k citations), Hematology (579 citations) and Psychiatry and Mental health (520 citations). Weichun Xu has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Mahboob U. Rahman, Désirée van der Heijde, Joyce A. Cramer, Dennis S. Charney, Robert A. Rosenheck, Sudha Visvanathan, Jonathan Thomas, Paul Williamson, William Henderson and Jürgen Braun. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and American Journal of Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact